Radiomics is an advancing field of medical image analysis based on extracting large sets of quantitative features that can be used for outcome modeling for clinical decision support. Our study investigated the value of radiomics features extracted from pre-treatment dynamic contrast-enhanced MRI for the prediction of neoadjuvant chemotherapy response in patients with triple-negative breast cancer. In a retrospective cohort of 103 TNBC patients, radiomics-based models using post-contrast images and kinetics maps were moderately predictive of pathologic response, and lesion size and shape features were the most consistent predictors across all image types.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords